![]() |
市場調查報告書
商品編碼
1949648
獸用化學分析儀市場 - 全球產業規模、佔有率、趨勢、機會及預測(按類型、產品、應用、最終用途、地區和競爭格局分類),2021-2031年Veterinary Chemistry Analyzer Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Product, By Species, By Application, By End-use, By Region & Competition, 2021-2031F |
||||||
全球獸用化學分析儀市場預計將從 2025 年的 31.3 億美元大幅成長至 2031 年的 68.1 億美元,複合年成長率為 13.83%。
這些診斷儀器對於分析血漿、尿液和血液樣本至關重要,可用於識別特定的蛋白質、電解質和代謝物,從而有助於控制和檢測家畜和伴侶動物的疾病。市場擴張的主要驅動力是全球對動物預防保健日益重視以及通用感染疾病的上升趨勢。此外,寵物飼養量的增加以及獸醫診所和實驗室對快速準確診斷結果的需求不斷成長,也進一步推動了對這些儀器的需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 31.3億美元 |
| 市場規模:2031年 | 68.1億美元 |
| 複合年成長率:2026-2031年 | 13.83% |
| 成長最快的細分市場 | 豬肉 |
| 最大的市場 | 北美洲 |
儘管市場呈現成長態勢,但仍面臨許多障礙,主要原因在於實施和維護這些先進分析系統高成本。根據美國寵物用品協會 (APPA) 預測,到 2024 年,美國獸醫保健支出和產品銷售額預計將達到 398 億美元,這表明人們對維護動物健康的強烈經濟投入支撐了對這類設備的需求。然而,高昂的購置門檻,尤其是在某些地區獸醫專業人員短缺的情況下,阻礙了此類設備的廣泛應用。因此,這些經濟因素可能會限制市場滲透,尤其是在資源有限的開發中國家。
寵物保險的日益普及正成為全球獸用化學分析儀市場的重要驅動力,顯著降低了寵物主人獲得先進診斷服務的經濟門檻。隨著保險範圍擴大,涵蓋的診斷項目增多,寵物飼主也更願意核准先前因費用問題而放棄的全面代謝篩檢和血液生化檢查。這種經濟支持使獸醫專業人員能夠更積極地實踐實證醫學,並利用院內化學分析儀進行慢性病監測和麻醉前檢查。北美寵物健康保險協會的數據也印證了這個趨勢,數據顯示,截至2025年4月,北美投保寵物的數量將增加至703萬隻,比上一年成長12.2%。這與照護現場技術的日益普及密切相關。
同時,不斷上漲的獸醫保健成本正在推動市場發展,而這又受到全球「寵物人性化」趨勢的驅動,即寵物被視為家庭成員。這種文化轉變促使飼主更願意投資於預防性護理和先進的疾病管理,從而維持了對快速、準確的化學分析的需求。根據澳洲動物藥品協會(Animal Medicines Australia)預測,到2025年9月,澳洲家庭在寵物上的支出預計將達到每年213億澳元,反映出動物健康已成為人們關注的重點。這種強勁的消費環境正在推動診斷公司的創新,凸顯了伴侶動物健康產業的韌性和擴張潛力。例如,碩騰(Zoetis)在2025年2月公佈的數據顯示,其2024會計年度全年營業收入成長了11%。
全球獸用化學分析儀市場成長的主要障礙之一是購買和維護先進診斷系統的高昂成本。尤其是中小型獨立獸醫診所,其利潤率通常較低,難以承擔高階分析儀所需的大量資本投入。除了初始購置成本外,持續的營運費用,例如專業技術支援、定期校準和專用試劑等,進一步增加了總擁有成本。因此,許多獸醫選擇將檢測外包給外部實驗室,以避免內部設備帶來的財務風險,這項決定直接降低了照護現場設備的銷售量。
更廣泛的經濟狀況進一步加劇了獸醫診所面臨的財務壓力。 2024年10月,獸醫院管理協會報告稱,過去12個月獸醫服務的通貨膨脹率上漲了8%,遠高於整體經濟的通貨膨脹以金額為準。營運成本的增加限制了可用於投資新技術的可用資金。由於診所在努力平衡不斷上漲的營運成本和維持價格敏感型客戶的穩定收費的同時,往往會推遲購買昂貴的診斷設備,導致已開發市場和新興市場的市場滲透率和成長停滯不前。
人工智慧 (AI) 和機器學習的整合正在改變全球獸用化學分析儀市場,實現自動化診斷解讀並提高工作流程效率。獸醫專業人員擴大利用人工智慧驅動的演算法來分析化學檢測結果,這一轉變最大限度地減少了人為錯誤,並加快了緊急情況下的臨床決策。這些技術直接整合到分析儀軟體中,可以檢測出原本會被忽略的異常情況,實際上相當於為從業人員提供了第二意見,並有助於緩解人員短缺問題。正如 Covetrus 在 2024 年 7 月發表的題為《人工智慧革命:技術如何改變獸醫學》的報導中所述,約 40% 的獸醫機構已經採用了人工智慧工具,這標誌著數位化診斷正在發生顯著轉變。
同時,隨著診所優先考慮快速就地檢驗( POCT)的普及速度正在加快。這一趨勢得益於緊湊型全自動桌上型系統的廣泛應用,這些系統使獸醫能夠在一次就診中完成全面的代謝指標檢測,從而提高飼主的留存率和治療效果。儘管整個產業面臨經濟壓力,但全球硬體安裝量的持續成長也印證了對診所內診斷能力的需求。例如,IDEXX Laboratories 在 2024 年 10 月發布的「2024 年第三季」財報中指出,其高階儀器的全球安裝量同比成長了 10%,這證實了診所對分析基礎設施的依賴性日益增強。
The Global Veterinary Chemistry Analyzer Market is projected to experience significant growth, expanding from USD 3.13 Billion in 2025 to USD 6.81 Billion by 2031 at a CAGR of 13.83%. These diagnostic instruments are essential for analyzing plasma, urine, and blood samples to identify specific proteins, electrolytes, and metabolites, thereby facilitating the management and detection of diseases in both livestock and companion animals. This market expansion is primarily underpinned by a growing global focus on preventive animal health and the increasing prevalence of zoonotic diseases. Additionally, the rise in pet ownership rates and the escalating need for rapid, precise diagnostic results in veterinary clinics and reference laboratories further strengthen the demand for these devices.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.13 Billion |
| Market Size 2031 | USD 6.81 Billion |
| CAGR 2026-2031 | 13.83% |
| Fastest Growing Segment | Porcine |
| Largest Market | North America |
Despite this growth trajectory, the market encounters substantial hurdles, primarily due to the high costs associated with acquiring and maintaining these sophisticated analytical systems. According to the American Pet Products Association, expenditure on veterinary care and product sales in the United States reached $39.8 billion in 2024, indicating a strong financial commitment to animal wellness that supports the demand for such equipment. However, the steep financial barrier of ownership, often exacerbated by a lack of skilled veterinary professionals in specific regions, poses a challenge to widespread adoption. Consequently, these economic factors may limit market penetration, particularly within developing economies where resources are constrained.
Market Driver
The increasing availability of pet insurance acts as a vital catalyst for the Global Veterinary Chemistry Analyzer Market, significantly reducing the financial obstacles to accessing advanced diagnostic care. As insurance policies expand to cover more diagnostic procedures, pet owners are increasingly willing to authorize comprehensive metabolic screenings and blood chemistry panels that were previously rejected due to cost. This financial support enables veterinary professionals to practice evidence-based medicine more assertively, utilizing in-house chemistry analyzers for chronic disease monitoring and pre-anesthetic testing. Data from the North American Pet Health Insurance Association highlights this trend, noting that by April 2025, the number of insured pets in North America had risen to 7.03 million by the end of 2024, a 12.2% increase from the prior year that correlates with higher usage of point-of-care diagnostics.
Simultaneously, the market is driven by rising expenditures on veterinary healthcare, fueled largely by the global trend of pet humanization, where animals are treated as essential family members. This cultural shift fosters a greater willingness among owners to invest in preventative healthcare and sophisticated disease management, thereby sustaining the demand for immediate and accurate chemical analysis. According to Animal Medicines Australia, national household spending on pets was projected to reach $21.3 billion annually by September 2025, reflecting a prioritization of animal wellness. This robust spending environment encourages diagnostic companies to innovate, as evidenced by Zoetis, which reported an 11% operational revenue growth for the full year 2024 in February 2025, underscoring the resilience and expansion of the companion animal health sector.
Market Challenge
The primary obstacle hindering the growth of the Global Veterinary Chemistry Analyzer Market is the substantial expense associated with purchasing and maintaining advanced diagnostic systems. Veterinary practices, especially small to medium-sized independent clinics, often operate with narrow profit margins, making the heavy capital investment required for high-end analyzers difficult to justify. Beyond the initial acquisition cost, the total cost of ownership is further inflated by recurring expenses for specialized technical support, regular calibration, and proprietary reagents. Consequently, many practitioners choose to outsource testing to external reference laboratories to avoid the financial risks of in-house equipment, a decision that directly reduces the sales volume of point-of-care devices.
This financial pressure is further intensified by the broader economic conditions affecting veterinary practice management. In October 2024, the Veterinary Hospital Managers Association reported that veterinary service inflation had risen by 8% over the previous twelve months, a rate significantly exceeding general economic inflation. This increase in operational costs limits the disposable capital available for investing in new technologies. As clinics struggle to balance rising overheads while maintaining stable fees for price-sensitive clients, the procurement of expensive diagnostic machinery is often postponed, effectively stalling market penetration and growth in both developed and emerging markets.
Market Trends
The Global Veterinary Chemistry Analyzer Market is being transformed by the integration of Artificial Intelligence and Machine Learning, which are automating diagnostic interpretation and improving workflow efficiency. Veterinary professionals are increasingly utilizing AI-driven algorithms to analyze chemistry results, a shift that minimizes manual errors and accelerates clinical decision-making during critical care situations. These technologies are being embedded directly into analyzer software to detect abnormalities that might otherwise be overlooked, effectively serving as a second opinion for practitioners and helping to mitigate staffing shortages. As noted in a July 2024 article by Covetrus titled 'The AI Revolution: How Technology is Transforming Veterinary Care,' nearly 40% of veterinary practices have adopted AI-enabled tools, indicating a significant move toward digitized diagnostics.
Concurrently, there is an accelerated adoption of Point-of-Care testing as clinics prioritize immediate turnaround times over outsourcing to reference laboratories. This trend is driven by the availability of compact, fully automated benchtop systems that allow veterinarians to perform comprehensive metabolic panels during a single office visit, thereby enhancing client compliance and treatment outcomes. The demand for these on-site diagnostic capabilities is evidenced by the continued expansion of hardware placements globally, despite industry-wide economic pressures. For instance, IDEXX Laboratories reported in its 'Third Quarter 2024 Results' in October 2024 that the company achieved a 10% year-over-year increase in its global installed base of premium instruments, underscoring the growing reliance on in-house analytical infrastructure.
Report Scope
In this report, the Global Veterinary Chemistry Analyzer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Chemistry Analyzer Market.
Global Veterinary Chemistry Analyzer Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: